Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending December 24, 2017
Prognostic Score System for Patients with PMF, J Clin Oncol; ePub 2017 Dec 9; Gugliemelli, et al
These Patients Are More Apt to Be Depressed, Ann Hematol; ePub 2017 Dec 7; Shreders, et al
Survival Length Shortest in These Patients with MF, Eur J Haematol; ePub 2017 Dec 11; Masarova, et al
The Value of Ruxolitinib Before and After AlloSCT, Blood; ePub 2017 Dec 7; Poulose, Malysz, et al
Tyrosine Kinase Inhibitors in Pediatric ALL, Hematology 2017; 2017 Dec 8; Silverman, et al
Must reads for theWeek ending December 17, 2017
Pharmacologic Tx of Seasonal Allergic Rhinitis, Ann Intern Med; ePub 2017 Nov 28; Wallace, et al
Risk of Obesity From Childhood into Adulthood, N Engl J Med; 2017 Nov 30; Ward, Long, et al
Labeling of Selective Androgen Receptor Modulators, JAMA; 2017 Nov 28; Van Wagoner, Eichner, et al
Oral Capsule vs Colonoscopy FMT for CDI, JAMA; 2017 Nov 28; Kao, Roach, et al
HIV Testing & Impact of Delayed Diagnosis, MMWR; 2017 Dec 1; Dailey, Hoots, et al
Must reads for theWeek ending December 10, 2017
Driver Mutations and Prognosis in PMF Assessed, Am J Hematol; ePub 2017 November 22; Tefferi, et al
Symptom Burden in People with MF, Thrombocytopenia, Leuk Res; 2017 Dec; Scotch, Kosiorek, et al
Consider This Method to Measure JAK2 Status in MF, Leuk Res; 2017 Dec; Strati, Benton, et al
Ruxolitinib + Azacytidine in MDS/MPNs Evaluated, Am J Hematol; ePub 2017 Nov 14; Assi, et al
Reappraising the Approach to PV and ET, Curr Opin Hematol; ePub 2017 Nov 30; Vannucchi, et al
Must reads for theWeek ending December 3, 2017
Potential US Population Impact of New BP Guideline, Circulation; ePub 2017 Nov 13; Muntner, et al
Can Sodium Reduction & DASH Diet Reduce BP?, J Am Coll Cardiol; ePub 2017 Nov 12; Juraschek, et al
Weight Loss Diets & All-Cause Mortality, BMJ; ePub 2017 Nov 14; Ma, Avenell, et al
Dabigatran vs Warfarin in Patients with AF, Ann Intern Med; ePub 2017 Nov 14; Go, et al
FDA Approves Fasenra for Severe Eosinophilic Asthma, AstraZeneca news release; 2017 Nov 14
Must reads for theWeek ending November 26, 2017
No Need to Alter TKI Treatment in These Patients, Am J Hematol; ePub 2017 Oct 13; Alhuraiji, et al
Insurance Subsidy Impact on New TKI Users Assessed, Cancer; ePub 2017 Oct 4; Shen, Zhao, Liu, et al
Ruxolitinib in Patients Who Can’t Take Hydroxyurea, Blood; 2017 Oct 12; Verstovsek, Passamonti, et al
Socioeconomic Status Impact on Chronic GVHD, Biol Blood Marrow Transplant; ePub 2017 Oct 12; Hamilton, et al
Impact of Precision-Dosing Strategy with IVIG, Pharmacotherapy; ePub 2017 Oct 13; Stump, et al